Fludarabine Phosphate (Hospira, Inc.)
Welcome to the PulseAid listing for the Fludarabine Phosphate drug offered from Hospira, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | FLUDARABINE PHOSPHATE |
SUBSTANCE NAME: | FLUDARABINE PHOSPHATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2008-09-25 |
END MARKETING DATE: | 0000-00-00 |
Fludarabine Phosphate HUMAN PRESCRIPTION DRUG Details:
Item Description | Fludarabine Phosphate from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/2mL) |
START MARKETING DATE: | 2008-09-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61703-344_5696ab73-377f-4315-9aff-952ed5edc054 |
PRODUCT NDC: | 61703-344 |
APPLICATION NUMBER: | ANDA077790 |
Other FLUDARABINE PHOSPHATE Pharmaceutical Manufacturers / Labelers: